Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Leggett & Platt | LEG | 24. dec 2024 | 9.72 | -0.61 |
Leidos | LDOS | 24. dec 2024 | 145.58 | +0.26 |
Leishen Energy Holding Co., Ltd. - Ordinary Shares | LSE | 24. dec 2024 | 5.00 | 0.00 |
LeMaitre Vascular | LMAT | 24. dec 2024 | 92.63 | +1.37 |
Lemonade | LMND | 24. dec 2024 | 41.27 | +3.43 |
LendingClub | LC | 24. dec 2024 | 16.66 | +2.08 |
LendingTree | TREE | 24. dec 2024 | 38.44 | +0.44 |
Lendway | LDWY | 24. dec 2024 | 4.54 | -9.20 |
Lennar A | LEN | 24. dec 2024 | 138.00 | 0.00 |
Lennar B | LEN-B | 24. dec 2024 | 134.17 | +0.27 |
Lennox International | LII | 24. dec 2024 | 631.13 | +0.97 |
LENSAR | LNSR | 24. dec 2024 | 8.69 | +0.46 |
LENZ Therapeutics | LENZ | 24. dec 2024 | 31.50 | +0.64 |
Leonardo DRS | DRS | 24. dec 2024 | 33.02 | +0.61 |
Lesaka Technologies | LSAK | 24. dec 2024 | 5.16 | +1.98 |
Leslies | LESL | 24. dec 2024 | 2.18 | 0.00 |
Levi Strauss & Co A | LEVI | 24. dec 2024 | 17.44 | +0.69 |
Lexaria Bioscience | LEXX | 24. dec 2024 | 2.21 | +0.45 |
Lexeo Therapeutics | LXEO | 24. dec 2024 | 6.35 | +2.25 |
Lexicon Pharmaceuticals | LXRX | 24. dec 2024 | 0.76 | -8.37 |
LexinFintech ADR | LX | 24. dec 2024 | 6.04 | +0.83 |
LG Display ADR | LPL | 24. dec 2024 | 3.42 | +0.89 |
LGI Homes | LGIH | 24. dec 2024 | 90.37 | -0.07 |
LGL Group | LGL | 24. dec 2024 | 6.15 | +3.36 |
Li Auto ADR | LI | 24. dec 2024 | 24.44 | +1.37 |
Li Bang International | LBGJ | 24. dec 2024 | 2.84 | 0.00 |
Li-Cycle | LICY | 24. dec 2024 | 1.57 | +2.61 |
Liberty Allstar Equity Fund | USA | 24. dec 2024 | 7.04 | +0.28 |
Liberty Allstar Growth Fund | ASG | 24. dec 2024 | 5.82 | +1.04 |
Liberty Broadband A | LBRDA | 24. dec 2024 | 76.22 | +0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.